Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > December report
View:
Comment by Ticklel1st on Dec 01, 2021 6:30pm
Since 2014: In return for the license, Wanbang provides upfront and milestone payments of up to US$9.5M in addition to royalty payments for product sales in the PRC. To date, Sirona has received $1.5 M in milestone payments.  WTF!!! That doesn't sound like a very strong committment to develop.
Comment by Ticklel1st on Dec 02, 2021 9:55am
So China has has had this for 7 years and only paid 1.5 million out of the 9.5 million in the deal. Now I know the management team is busy doing real jobs and Sirona is not their real gig...even though the get paid real well...but should China have been paying more over 7 years? Howhee...do you care to comment on this publically or are you to too busy to offer up an explanation?  I think ...more  
Comment by biorun on Dec 02, 2021 11:06am
Wanbang has invested north of $5M USD on their end, so it will be interesting where this goes next. It is possibly evident from the IP registration that Wanbang may be in the bed with Elanco, Boehringer and Sirona on the pet side. Sounds juicy but only if they agree on the next step. 
Comment by Ticklel1st on Dec 02, 2021 3:02pm
BIOran. I think you can change that around and say China spent 5 million$ of Sirona money on their end as they have not paid Sirona any money other than the 1.5$ Tht would be the logical take on who is paying for what. Howhee. Have you set benchmarks and sent invoices for payment? Or has the Chinese New Year over that last 4-5 years prevented payment. I think for transparency, can you enlighten ...more  
Comment by biorun on Dec 02, 2021 3:30pm
The next installment comes phase 3. 
Comment by Ticklel1st on Dec 02, 2021 8:43pm
BIOran. So, China is not at stage 3 yet. When they get to 3 they pay another 1.5 Million? It's taken 7 years to get to stage 2 and let's say they make stage 3 in 2022 baring any chinese new year delays or other excuses management can come up with. So, logic says that at every 2 stages completed they pay 1.5. Sound about right? & years and the get about 30% of the 9.5 million.   ...more  
Comment by Pandora on Dec 02, 2021 4:52pm
Just two words ---- "It's China".
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities